|
AAGAB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.1734950485004E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.08029951440392E-10 |
| Normal-vs-Stage2 |
5.537800E-02 |
| Normal-vs-Stage3 |
1.60950142102934E-11 |
| Normal-vs-Stage4 |
1.74293912635903E-12 |
| Stage1-vs-Stage2 |
5.897800E-03 |
| Stage1-vs-Stage3 |
1.383630E-01 |
| Stage1-vs-Stage4 |
9.183900E-04 |
| Stage2-vs-Stage3 |
1.937490E-03 |
| Stage2-vs-Stage4 |
4.22230000000079E-05 |
| Stage3-vs-Stage4 |
7.929900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46339631920978E-11 |
| Normal-vs-AfricanAmerican |
2.959600E-04 |
| Normal-vs-Asian |
4.60239957256192E-10 |
| Caucasian-vs-AfricanAmerican |
4.379400E-01 |
| Caucasian-vs-Asian |
3.214200E-01 |
| AfricanAmerican-vs-Asian |
1.557620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.29929999881773E-09 |
| Normal-vs-Female |
3.1978997228066E-10 |
| Male-vs-Female |
8.395200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.39580014213436E-10 |
| Normal-vs-Age(41-60Yrs) |
9.81760006624199E-10 |
| Normal-vs-Age(61-80Yrs) |
1.61859999958658E-07 |
| Normal-vs-Age(81-100Yrs) |
5.676700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.549200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.287800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.290600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.599800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.890400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.812000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.24770000000807E-05 |
| Classical-VS-Follicular |
4.399200E-04 |
| Classical-VS-Other |
1.977370E-01 |
| Classical-VS-Normal |
1.0478951040227E-11 |
| Tall-VS-Follicular |
1.11340000552573E-08 |
| Tall-VS-Other |
7.413400E-01 |
| Tall-VS-Normal |
1.72895031624876E-12 |
| Follicular-VS-Other |
4.241900E-02 |
| Follicular-VS-Normal |
1.721680E-02 |
| Other-VS-Normal |
5.55209999999473E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11109999978432E-07 |
| Normal-vs-N1 |
6.10622663543836E-15 |
| N0-vs-N1 |
1.46119999999694E-06 |
|
|
